Balancing cardiovascular (CV) and cancer death among patients with small renal masses: Modification by CV risk

BJU International

Volumn 115, Issue 1, 2015, Pages 58-64

  Patel, Hiten D ^a,b,c   Kates, Max ^a   Pierorazio, Phillip M ^a   Allaf, Mohamad E ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

active surveillance; comorbidity; Medicare; renal cell carcinoma; SEER; small renal mass

Indexed keywords

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; CANCER MORTALITY; CANCER SPECIFIC SURVIVAL; CARDIOVASCULAR RISK; COMORBIDITY; DEMOGRAPHY; FEMALE; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICARE; MIDDLE AGED; NEPHRECTOMY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; REGISTER; TUMOR VOLUME; VERY ELDERLY; CANCER REGISTRY; CARCINOMA, RENAL CELL; CARDIOVASCULAR DISEASE; EPIDEMIOLOGY; KIDNEY NEOPLASMS; MORTALITY; RETROSPECTIVE STUDY; RISK; SURVIVAL ANALYSIS; TIME TO TREATMENT; UNITED STATES;

AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; NEPHRECTOMY; RETROSPECTIVE STUDIES; RISK; SEER PROGRAM; SURVIVAL ANALYSIS; TIME-TO-TREATMENT; UNITED STATES;

EID: 84928275338     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12719     Document Type: Article

References (30)

1. Kane CJ, Mallin K, Ritchey J, Cooperberg MR, Carroll PR,. Renal cell cancer stage migration: analysis of the National Cancer Data Base. Cancer 2008; 113: 78-83
2. Patel HD, Mullins JK, Pierorazio PM, et al. Trends in renal surgery: robotic technology is associated with increased use of partial nephrectomy. J Urol 2013; 189: 1229-1235
3. Jewett MAS, Mattar K, Basiuk J, et al. Active surveillance of small renal masses: progression patterns of early stage kidney cancer. Eur Urol 2011; 60: 39-44
4. Pierorazio PM, Hyams ES, Mullins JK, Allaf ME,. Active surveillance for small renal masses. Rev Urol 2012; 14: 13-19
5. Kutikov A, Egleston BL, Canter D, Smaldone MC, Wong YN, Uzzo RG,. Competing risks of death in patients with localized renal cell carcinoma: a comorbidity based model. J Urol 2012; 188: 2077-2083
6. Miller DC, Schonlau M, Litwin MS, Lai J, Saigal CS, Diseases U,. in America Project. Renal and cardiovascular morbidity after partial or radical nephrectomy. Cancer 2008; 112: 511-520
7. Kates M, Badalato GM, Pitman M, McKiernan JM,. Increased risk of overall and cardiovascular mortality after radical nephrectomy for renal cell carcinoma 2 cm or less. J Urol 2011; 186: 1247-1253
8. Huang WC, Elkin EB, Levey AS, Jang TL, Russo P,. Partial nephrectomy versus radical nephrectomy in patients with small renal tumors- Is there a difference in mortality and cardiovascular outcomes? J Urol 2009; 181: 55-61
9. Smaldone MC, Kutikov A, Egleston BL, et al. Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis. Cancer 2012; 118: 997-1006
10. Sun M, Becker A, Tian Z, et al. Management of localized kidney cancer: calculating cancer-specific mortality and competing risks of death for surgery and nonsurgical management. Eur Urol 2014; 65: 235-241
11. Patel HD, Kates M, Pierorazio PM, et al. Survival after diagnosis of localized T1a kidney cancer: current population-based practice of surgery and nonsurgical management. Urology 2014; 83: 126-133
12. Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999; 100: 1043-1049
13. Kannel WB,. Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA 1996; 275: 1571-1576
14. Miller DC, Saigal CS, Warren JL, et al. External validation of a claims-based algorithm for classifying kidney-cancer surgeries. BMC Health Serv Res 2009; 9: 92
15. Cooper GS, Virnig B, Klabunde CN, Schussler N, Freeman J, Warren JL,. Use of SEER-Medicare data for measuring cancer surgery. Med Care 2002; 40 (Suppl.): IV-43-201048
16. Yang G, Villalta JD, Meng MV, Whitson JM,. Evolving practice patterns for the management of small renal masses in the USA. BJU Int 2012; 110: 1156-1161
17. Deyo RA, Cherkin DC, Ciol MA,. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45: 613-619
18. Charlson ME, Pompei P, Ales KL, MacKenzie CR,. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987; 40: 373-383
19. Brevetti G, Giugliano G, Oliva G, Lanero S, De Maio JI, Chiariello M,. The impact of comorbidity burden on the cardiovascular risk in the Peripheral Arteriopathy and Cardiovascular Events study. QJM 2008; 101: 575-582
20. Pearte CA, Furberg CD, O'Meara ES, et al. Characteristics and baseline clinical predictors of future fatal versus nonfatal coronary heart disease events in older adults: the Cardiovascular Health Study. Circulation 2006; 113: 2177-2185
21. Robbins JM, Webb DA, Sciamanna CN,. Cardiovascular comorbidities among public health clinic patients with diabetes: the Urban Diabetics Study. BMC Public Health 2005; 5: 15
22. Fine JP, Gray RJ,. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496-509
23. Berger DA, Megwalu II, Vlahiotis A, et al. Impact of comorbidity on overall survival in patients surgically treated for renal cell carcinoma. Urology 2008; 72: 359-363
24. Ather MH, Nazim SM,. Impact of Charlson's comorbidity index on overall survival following tumor nephrectomy for renal cell carcinoma. Int Urol Nephrol 2010; 42: 299-303
25. Patel HD, Allaf ME,. Re: Maxine Sun, Andreas Becker, Zhe Tian et al. Management of localized kidney cancer: calculating cancer-specific mortality and competing risks of death for surgery and nonsurgical management. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.03.034. Eur Urol 2013; 64: e105-106
26. Shuch B, Hanley J, Lai J, et al. Overall survival advantage with partial nephrectomy: a bias of observational data? Cancer 2013; 119: 2981-2989
27. Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK,. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 2006; 98: 1331-1334
28. Patnaik JL, Byers T, Diguiseppi C, Denberg TD, Dabelea D,. The influence of comorbidities on overall survival among older women diagnosed with breast cancer. J Natl Cancer Inst 2011; 103: 1101-1111
29. Patel HD, Kates M, Pierorazio PM, et al. Comorbidities and Causes of Death in the Management of Localized T1a Kidney Cancer. Int J Urol 2014 (in press)
30. Bhan SN, Pautler SE, Shayegan B, Voss MD, Goeree RA, You JJ,. Active surveillance, radiofrequency ablation, or cryoablation for the nonsurgical management of a small renal mass: a cost-utility analysis. Ann Surg Oncol 2013; 20: 3675-3684